AR049337A1 - 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina - Google Patents
7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrinaInfo
- Publication number
- AR049337A1 AR049337A1 ARP050101934A ARP050101934A AR049337A1 AR 049337 A1 AR049337 A1 AR 049337A1 AR P050101934 A ARP050101934 A AR P050101934A AR P050101934 A ARP050101934 A AR P050101934A AR 049337 A1 AR049337 A1 AR 049337A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- linear
- branched
- phe
- integer
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000732 arylene group Chemical group 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 abstract 1
- 125000006586 (C3-C10) cycloalkylene group Chemical group 0.000 abstract 1
- -1 4-carboxybenzyl Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000005915 C6-C14 aryl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005724 cycloalkenylene group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000242A ITRM20040242A1 (it) | 2004-05-13 | 2004-05-13 | "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049337A1 true AR049337A1 (es) | 2006-07-19 |
Family
ID=35124315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101934A AR049337A1 (es) | 2004-05-13 | 2005-05-12 | 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7589099B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1747020A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007537243A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101065150A (cg-RX-API-DMAC7.html) |
| AR (1) | AR049337A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005243883A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0511077A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2562569A1 (cg-RX-API-DMAC7.html) |
| IT (1) | ITRM20040242A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06012885A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200538123A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005110486A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040239A1 (it) * | 2004-05-13 | 2004-08-13 | Sigma Tau Ind Farmaceuti | Derivati ciclopeptidici ad attivita' antintegrine. |
| WO2011086553A1 (en) * | 2010-01-13 | 2011-07-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules |
| CN103275094B (zh) * | 2013-05-08 | 2015-07-08 | 中国农业科学院植物保护研究所 | (20s)-喜树碱的衍生物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19815812A1 (de) * | 1998-04-08 | 1999-10-14 | Bayer Ag | Modifizierte Cytostatika |
| ES2175919T3 (es) * | 1999-03-09 | 2002-11-16 | Sigma Tau Ind Farmaceuti | Derivados del camptothecin con actividad antitumoral. |
| ITRM20020306A1 (it) * | 2002-05-31 | 2003-12-01 | Sigma Tau Ind Farmaceuti | Esteri in posizione 20 di camptotecine. |
-
2004
- 2004-05-13 IT IT000242A patent/ITRM20040242A1/it unknown
-
2005
- 2005-04-28 JP JP2007512729A patent/JP2007537243A/ja not_active Withdrawn
- 2005-04-28 US US11/596,016 patent/US7589099B2/en not_active Expired - Fee Related
- 2005-04-28 WO PCT/IT2005/000245 patent/WO2005110486A2/en not_active Ceased
- 2005-04-28 EP EP05743414A patent/EP1747020A2/en not_active Withdrawn
- 2005-04-28 MX MXPA06012885A patent/MXPA06012885A/es not_active Application Discontinuation
- 2005-04-28 BR BRPI0511077-7A patent/BRPI0511077A/pt not_active IP Right Cessation
- 2005-04-28 CA CA002562569A patent/CA2562569A1/en not_active Abandoned
- 2005-04-28 CN CNA2005800152130A patent/CN101065150A/zh active Pending
- 2005-04-28 AU AU2005243883A patent/AU2005243883A1/en not_active Abandoned
- 2005-05-04 TW TW094114400A patent/TW200538123A/zh unknown
- 2005-05-12 AR ARP050101934A patent/AR049337A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200538123A (en) | 2005-12-01 |
| BRPI0511077A (pt) | 2007-12-26 |
| AU2005243883A1 (en) | 2005-11-24 |
| WO2005110486A3 (en) | 2007-03-08 |
| JP2007537243A (ja) | 2007-12-20 |
| CN101065150A (zh) | 2007-10-31 |
| EP1747020A2 (en) | 2007-01-31 |
| MXPA06012885A (es) | 2007-08-14 |
| US20070225311A1 (en) | 2007-09-27 |
| WO2005110486A2 (en) | 2005-11-24 |
| CA2562569A1 (en) | 2005-11-24 |
| ITRM20040242A1 (it) | 2004-08-13 |
| US7589099B2 (en) | 2009-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
| ECSP088246A (es) | Nuevos derivados de benzotiazolona | |
| HN2002000319A (es) | Benzamida, heteroarilamida y amidas inversas | |
| ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
| ATE457781T1 (de) | Orale zusammensetzungen mit extrakten von rosmarin und zugehörige verfahren | |
| CY1113267T1 (el) | Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1 | |
| HN2002000154A (es) | Azaindoles | |
| AR035285A1 (es) | Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion. | |
| BRPI0513460A (pt) | composição aquosa suave apropriada para a limpeza do cabelo e da pele | |
| BR0116168A (pt) | Formulação repelente de inseto liberável por dispositivo piezelétrico | |
| AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
| ECSP067062A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| ECSP066950A (es) | Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2 | |
| CY1111983T1 (el) | Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο | |
| MX9602806A (es) | Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales. | |
| BRPI0212298B8 (pt) | composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico | |
| CL2008002429A1 (es) | Compuestos derivados de n-bencil, n'-arilcarbonilpiperazina, con actividad agonista de los receptores x del higado (lxrs); composicion farmaceutica que los contiene; y el uso de los compuestos en el tratamiento de la aterosclerosis. | |
| EA200600528A1 (ru) | Способ получения водорастворимых дитерпенов и их применение | |
| AR048949A1 (es) | Camptotecina conjugada en posicion 7 con antagonistas de la integrina | |
| CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
| CL2004001012A1 (es) | Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica | |
| AR049337A1 (es) | 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina | |
| AR030537A1 (es) | Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos | |
| AR044275A1 (es) | Uso de derivados de sulfonamidas para la fabricacion de un medicamento para la profilaxis y/o tratamiento de las disfunciones alimentarias | |
| MX2024009773A (es) | Composicion farmaceutica que comprende derivados de difenildiazol y metodos de uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |